Company Analysis

Veracyte, Inc. (VCYT)

Nasdaq: VCYT · Services-Medical Laboratories · South San Francisco, CA · filing with the SEC since 2006
Grade6.3
◀ Past 6.2● Present 6.6▶ Future 6.1

Who runs Veracyte, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Stapley Marc
Chief Executive Officer. First filing Jun 2021, latest Sep 4, 2026, 7 filings in all.
Officers reporting now
7
of 15 people with a filing in the last fifteen months
Directors reporting now
8
29 people on the record since 2013
Officerssales are open-market, Oct 29, 2025 to Oct 29, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Wygant JonathanVP, Chief Accounting OfficerMar 2022Oct 29, 20263 · $1.5M
Leite JohnGlobal Chief Commercial OffSep 2023Sep 22, 20265 · $1.2M
Stapley MarcChief Executive OfficerJun 2021Sep 4, 20265 · $8.9M
Chambers RebeccaChief Financial OfficerJul 2021Sep 4, 20269 · $1.9M
Febbo Phillip G.Chief Scientific & Med OfficerOct 2023Sep 4, 20263 · $1.0M
Mcguire AnnieEVP, General CounselFeb 2022Sep 4, 202613 · $1.7M
Haas Kevin RichardChief Dev and Tech OfficerMar 2026Apr 14, 2026none
Directorssales are open-market, Oct 29, 2025 to Oct 29, 2026
NameRoleFirst filingLatest filingSales, 12 months
Eastham KarindirectorOct 2013Oct 28, 20267 · $2.2M
Holstein JensdirectorAug 2020Oct 28, 20266 · $1.4M
Bhanji MunadirectorMar 2021Oct 20, 20262 · $200,000
Barr EliavdirectorAug 2022Jun 15, 2026none
Epstein Robert SdirectorJan 2015Jun 15, 20261 · $400,000
Jones Evan/ FadirectorOct 2013Jun 15, 20267 · $2.0M
Miller Thomas F.directorSep 2024Jun 15, 2026none
Shafer David BrentdirectorSep 2024Jun 15, 2026none
Earlier names on the record19, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton VCYT · research, not advice